Great Deal! Get Instant $10 FREE in Account on First Order + 10% Cashback on Every Order Order Now

Circulating_tumor_cells.pdf fl fi fl Aliquot ranking Active sorting On-chip purification Secondary labeling Downstream analyses 5 4 3 2 1 Add antibodies Add isoton Remove supernatant Mix Label Dilute...

1 answer below »
Circulating_tumor_cells.pdf
fl
fi
fl
Aliquot ranking
Active sorting
On-chip purification
Secondary labeling
Downstream analyses
5
4
3
2
1
Add
antibodies
Add
isoton
Remove
supernatant Mix
Label Dilute RunSpin
Blood(a)
(e) Cell
capture
Waste
(d)
Sorting
Aliquot
detection
Aliquot
detection
Sorting
confirmed
Time
In
te
ns
ity
(f)
Buffe
(b) (c)
fl
fl
fl μ
fl
μ μ
× μ μ
0
20
0
20 40
40
EpCAM signal to noise
60
Mean S/N ratio
for cells
60
80
80
100
70–80
60–70
50–60
40–50
30–40
20–30
0
20
6040200
0
600
0
0
0
250
500
750
488 nm
lase
633 nm
lase
APD 3
APD 2
APD 1
APD 4
CCD
camera
Objective
In
te
ns
ity
150
1500
Time (s)
(b)
(d)
(c)
(a)
EpCAM sorting
Control
Her2
EpCAM
40
60
80
S
ig
na
l t
o
no
is
e
a
tio
10–20
0–10
0.8
0.6
0.4
De
tec
tion
bin
Tim
e (m
s)0
.2
140Flow rate (μl/min)
7510 0
100
H
e
2
si
gn
al
to
n
oi
se
fl
fl
fl
fl
μ
fl
fl
XXXXXXXXXXActive Sorting Scheme Based on an On-Chip Solenoid
fl
600
400
200
0
0 500
200
μm
XXXXXXXXXX
Time (ms)
(a) (b) (c) (d)
1500
750
1000
500
250
0
XXXXXXXXXX
Time (ms)
1500
In
te
ns
tiy
fl
fi
μ
fl < μ
fl μ
XXXXXXXXXXActive Sorting Scheme Based on an Off-Chip Solenoid fi
μ fi
fl
fi
fl
fl
fi
fl
Time (ms)
Decision APD traces
Waste WasteFilte
WasteFilte
Buffer Buffe
Buffe
Inlet
OutletOutlet 3 mm
Inlet
Microfluidic chip
Inlet
Blood inlet
Buffe
Buffe
Blood
Blood
Waste
Confirmation
laser line
Pressurized
N2 gas
Pressurized
N2 gas
P2P1 P3
NC
solenoid
valve
Detection laser line
Filte
BufferBuffe
Blood
Confirmation APD traces
1000
0
500
1000
1500
In
te
ns
ity
1200
(a) (d)
(e)
(c)
(b)
fl
fl μ
μ
400
200
F
e
qu
en
cy
Transit time (ms)
T
a
ns
it
tim
e
(m
s)
0
0
Flow rate (μl/min)
40 μl/min
80 μl/min
XXXXXXXXXX
0
5
10
15
XXXXXXXXXX
(f) (g)
fl μ
fl
μ
fl
fi
XXXXXXXXXXPurification via Integrated Planar Filter fi
μ
×
(b) (c) (d)(a)
Filte
Cell capture
chambe
fi fi
fi
μ
fi
XXXXXXXXXXPurification viaMicrofa
icated Slits fi
fi
fi
fi
μ
fi
fi
WBC RBC
CTC
5 μm
EpCAM
GFP-MDA-MB-231
(a)
(b) (d)
(c)
fl μ
fi
fi
+
EpCAM
EpCAM
E
pC
A
M
Her2 CD45
C
D
44
C
D
24
C
el
l 3
C
el
l 2
C
el
l 1
Cytokeratin
Cytokeratin Her2 Hoechst Merged
Draq5
CTC
Stem cell
(b)(a)
(c)
μ
+
fi
fi
fi
μ
fl μ fl
fl μ fl
μ
40
0
50
100
P
e
ce
nt
ag
e
(%
)
75
50
25
100
105
Volume (ml)
1
R
ec
ov
e
y
(%
)
75
50
25
MC
F-7
wi
th E
pC
AM
SK
Br-
3 w
ith
He
-2
MD
A-M
B-2
31-
GF
P
MD
A-M
B-2
31
wit
h E
GF
R
100
R
ec
ov
e
y
(%
)
R
ec
ov
e
ed
n
um
e
60
Flow rate (μl/min)
(a) (b)
(c) (d)
80
Recovery
Sorting efficiency
100 100
Spiked in numbe
10
1000 Y = 0.95 X
R2 = 0.998
100
10
1
1000
fi
fi
μ
fl
μ
fi
fi
fi
fl μ
=
fi
fi
μ
1 2
0
30
60
90
120
eDAR results
CellSearch
esults
C
T
C
p
e
7
.5
m
l
XXXXXXXXXX
Patient sample numbe
XXXXXXXXXX XXXXXXXXXX
fi
fi
=
? =
Second
generation
of eDAR
First
generation
of eDAR
Second
generation
of eDAR
0
50C
T
C
s
m
l
100
Healthy blood samples
Pancreatic cancer samples
1000
fi
∼
Waste out
(a) (b)
Repeat this process
Cells captured
y eDAR
Fixation Washing and
permeabilization
Washing
and imaging
Photobleach
Staining with
a group of
iomarkers
Staining and
imaging area
Buffer or labeling
eagents in
P
fi
fl
fi
First
ound
P
E
A
le
xa
64
7
O

A
P
C
H
oe
ch
st
F
IT
C
M
e
ge
d
Second
ound
Third
ound
Fourth
ound
Afte
leach
EpCAM
Cytokeratin
Hoechst
CD45
MUC1
Her2
Hoechst
CD45
CD24
CD44
Hoechst
CD45
CD166
EGFR
Hoechst
CD45
Afte
leach
Afte
leach
μ
CD45
EpCAM
400
Microchip
APDs
488 nm lase
633 nm lase
EpCAM–
phycoerythrin
Cytokeratin–
Alexa 647
200
400
200
160
CytokeratinI
nt
en
si
ty
180 200
160 180
Time (ms)
200
0(a)
(c) (b)
fi
+ + +
fl
fi
+ +
0
0
1
10
100
1000
10,000
C
T
C
s
7
. m
l
20
Flow detection results
Threashold determined by Z-test
Threashold = Mean background + 2 × standard deviation
Simple threashold
CellSearch results
40
Patient numbe
60 80
fl
+ + +
0
0
10
100
1000
10,000
N
um
e

of
c
el
ls
p
e
7
.5
m
l o
f
lo
od
1
5 10
CTCs counts using CellSearch assay
CTC counts using flow detection system
EpCAM+/CD44+/CD24− counts using flow detection system
15
Patient numbe
XXXXXXXXXX
+ + − fl
fl
+ + −
0
100
eDAR Flow count Flow counteDAR
200
300
400
500
C
T
C
s
7.
5
m
l o
f
lo
od 600
700
800
fl
fl
fl
= ? =
fl
fi
fi
fl
fl
fl
Answered Same Day May 10, 2021

Solution

Soumi answered on May 15 2021
151 Votes
ENSEMBLE-DECISION ALIQUOT RANKING (eDAR) FOR CTC ISOLATION AND ANALYSIS: A STUDY REPORT
Table of Contents
Introduction    3
Theories    3
Analysis    4
Conclusion    5
Bibliography    7
Introduction
The ideal method to isolate the rare cells such as circulating tumor cells (CTC) needs to fulfil four criteria. The method must be capable of high throughput so that milliliters of entire blood can be processed fast like within ten minutes. Method must be highly efficient and sensitive and the percentage of recovery must be higher than 90 per cent. Its limit of detection must be close to 1 CTC per blood sample. It must be capable of easily recovering live CTC with high purity. At last, it must be robust and economical to operate. To mitigate the problem, a new method called eDAR (ensemble-division aliquot ranking). This method is based on positive selection, in which blood samples are labelled with specific antibodies conjugated with fluorophores, then blood samples are divided in nanoliter aliquot that are optically checked and ranked for the absence or presence of the circulating tumor cells [1].
Theories
Ensemble-division aliquot ranking ensemble cells within each aliquot and ranked them in a single scan. It helps in selecting the aliquot of cells that must be investigated without compromising the throughput. Throughput is a key bottleneck in applying flow cytometry for CTC isolation. In traditional flow cytometry, the throughput is limited by the sequential analysis of individual cells. This took over 24 hours for 1 ml of blood containing 5 billion cells [11]. This throughput constraint is one of the main reasons that flow cytometry able to analyze only fractioned blood in CTC detection. This is done either by lysing red blood cell or by centrifuging the blood with density gradient buffer to isolate nucleated cells.
eDAR works like the flow cytometry yet there is significance difference. To manage the throughput, eDAR probes for rare cells in nanoliter aliquot of blood, so that each aliquot contains thousands of cells. High sensitivity of detection scheme able to detect one CTC per few nanoliter of blood in milliseconds. Aliquot containing CTC are automatically sorted and collected in small region of microfluid chip. In that region, purification method is applied. The isolated CTC can be imaged on microchip or restrained with biomarkers for further analysis [2].
eDAR provides three or four magnitude of improvement in throughput compared to other flow cytometry. Other methods spread the isolated the cell throughout the large area or on multiple slides, in contrast, eDAR trapped the cells in smaller area for rapid subsequent imaging. It isolated the rare cells from abundance of the cell. This method is elegant yet posed certain limitation to the process. Ensemble ranking process limits eDAR to the isolation of rare cells and prevent them from working well on target cells, which are, present in abundant. Despite the vast improvement in the method, eDAR is limited to the information from the fluorescence. Information using the light scattering data cannot be obtained due to large number of cells within the vicinity [3]. Flow cytometry detect in a single profile format allowed to obtain data from both fluorescence and light scattering. eDAR gives reduced hydrodynamic-induced cell stress. eDAR resultant into linear flow in cytometry, which minimizes shear stress on the cell. It preserves the viability of the rare...
SOLUTION.PDF

Answer To This Question Is Available To Download

Related Questions & Answers

More Questions »

Submit New Assignment

Copy and Paste Your Assignment Here